A tailored dose of tenofovir could reduce its impact on bone mass in HIV type 1-infected children and adolescents: A report from 5 years of clinical experience

Raffaella Rosso, Arianna Parodi, Chiara Torrisi, Francesca De Terlizzi, Claudio Viscoli, Marina Vignolo

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1265-1266
Number of pages2
JournalAIDS Research and Human Retroviruses
Issue number12
Publication statusPublished - Dec 1 2010

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this